Protein discovery leads to new hyperparathyroidism drug target
A new signalling protein discovery could lead to drug-based therapies to treat hyperparathyroidism.
List view / Grid view
A new signalling protein discovery could lead to drug-based therapies to treat hyperparathyroidism.
New study describes for the first time the structure of Ixolaris and its action on the inhibition of thrombus formation.
New findings could be translated into the development of novel treatments for patients with optic neuropathies.
A new method of assessing the actions of medicines by matching them to their unique protein receptors could accelerate drug development.
Findings from a recent study could lead to the development of therapeutic approaches against influenza A viruses.
Researchers have discovered an acid-activated protein which could stop damage to tissues as a result of stroke and other health issues.
A machine-learning model has been developed to analyse protein sequences, giving an insight to their structure, function and phylogeny...
Researchers have discovered an immune regulator that appears to dictate glioblastoma progression by shutting down immune surveillance...
Researchers have developed the first viable mouse model of Hirschsprung’s disease and associated enterocolitis with a defect in GDNF/GFRa1/RET signalling...
Find out how to streamline Cell Line Development by identifying high-producing clones with monoclonality assurance in one day.
Liquid-phase electron microscopy could overcome limitations identified through traditional protein imaging techniques and through cro-electron microscopy...
G protein-coupled receptors (GPCRs) are seven transmembrane spanning proteins that mediate the physiological responses to a broad array of stimuli, including photons, biogenic amines, peptides and large proteins. They represent the target of approximately one-third of all approved drugs,1 yet paradoxically remain a relatively under-exploited protein class.
In the wake of the human genome project, molecular biology and genetic technologies are tremendously integrating into biomedical research. Currently, PCR, qPCR, and sequencing are key tools in the clinical laboratory for the detection and characterisation of microorganisms and genetic disorders.
Discovery based on analysis of tissue and saliva samples from oral cancer patients shows a correlation between a signature comprising three peptides and the presence of lymph node metastasis...
The Small Molecule Screening Facility (SMSF) at the University of Wisconsin Madison is a comprehensive high-throughput screening (HTS) centre where researchers have investigated antibiotic-resistant bacterial infections and screening for protein-protein interactions using HTS methods.